Latest news with #BlakeFallis
Yahoo
17 hours ago
- Business
- Yahoo
Boron One Announces Closing of Financing
VICTORIA, BC / / June 19, 2025 / Boron One Holdings Inc. ("Boron One" or the "Company") [TSXV:BONE]") is pleased to announce that the Company has accepted subscriptions for 4,120,000 units at a price of $0.05 per unit, for gross proceeds of $206,000. Each unit is comprised of one common share and one common share purchase warrant, exercisable at $0.05 for one year, and $0.07 for 2 further years. The Common Shares and Warrants comprising the Units will be subject to a four-month and one day hold period in accordance with the policies of the TSX Venture Exchange and applicable securities legislation. The Company intends to use net proceeds of the Private Placement for working capital requirements. The Private Placement is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including approval from the TSX Venture Exchange. On behalf of the Board of Directors,Tim Daniels, President About Boron One Holdings Inc. Boron One Holdings Inc. is an international mineral exploration and development company with boron assets in Serbia. Headquartered in Victoria, B.C., Canada, Boron One's shares are traded on the TSX Venture Exchange under the symbol "BONE". For detailed information please see Boron One's website at or the Company's filed documents at For further information, please contact:Boron One Holdings Fallis, General ManagerPhone: 1-250- 384-1999 or 1-888-289-3746info@ Boron's Public Quotations:CanadaTSX Venture: BONEBerlin: EKVUS: SEC 12G3-2(B) #82-4432ERVFFOTCBB: ERVFF Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE: Boron One Holdings Inc. View the original press release on ACCESS Newswire
Associated Press
25-04-2025
- Business
- Associated Press
AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus
Restructured agreement increases capital efficiency, simplifies revenue structure, and expands future opportunity. VANCOUVER, BC / ACCESS Newswire / April 25, 2025 / AI/ML Innovations Inc. ('AIML' or the 'Company') (CSE:AIM)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it has entered into an agreement dated April 11, 2025 (the 'Restructuring Agreement') setting forth certain revised terms and conditions in respect of its recent acquisition of all of the issued and outstanding shares of Quantum Sciences Ltd. ('Quantum') which was closed on December 23, 2024 (the 'Acquisition'). The Acquisition was previously completed pursuant to an agreement of purchase and sale dated December 9, 2024, as amended December 20, 2024, between the Company and the vendors of Quantum (the 'Vendors'). The original consideration for the Acquisition was the issuance of 10,000,000 common shares in the capital of the Company (the 'Consideration Shares'). In addition, immediately prior to the closing of the Acquisition, Quantum granted royalties on the sale of all cardiology related products sold by Quantum (the 'Royalties') in the amount of 4%, to be divided equally amongst the four Vendors, with each Vendor entitled to 1% of such sales. Pursuant to the Restructuring Agreement, the terms and conditions of the Acquisition have been amended to provide for revised consideration, including as follows: The Restructuring Agreement remains subject to the approval of the Canadian Securities Exchange, as well as the satisfaction of other standard closing conditions. This restructuring is part of AIML's broader effort to streamline its operational model and focus resources on high-growth areas within AI-powered health solutions. By simplifying the acquisition structure, AIML improves its flexibility for future investment, strategic partnerships, and accelerated innovation. For more information about AIML: For detailed information please see AIML's website or the Company's filed documents at Contact: Blake Fallis (778) 405-0882 [email protected] About AI/ML Innovations Inc. AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its wholly owned subsidiaries, Quantum Sciences Ltd. and NeuralCloud Solutions Inc, AI Rx Inc., strategic partnerships with Health Gauge Inc. (95.2% owned by AIML), and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AIML's shares are traded on the Canadian Securities Exchange under the symbol 'AIML', the OTCQB Venture Market under 'AIMLF', and the Frankfurt Stock Exchange under '42FB'. On behalf of the Board of Directors: Paul Duffy, Chairman Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including statements with respect to the completion of the transactions contemplated by the Restructuring Agreement as currently proposed or at all. Such statements remain subject to various risks, including risks relating to the receipt of all applicable regulatory approvals and the satisfaction of all closing conditions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company disclaims any obligation to update such forward-looking statements other than as required by law. SOURCE: AI/ML Innovations, Inc. press release
Yahoo
22-04-2025
- Business
- Yahoo
Boron One Announces Update to Early Warrant Exercise Incentive Program
VICTORIA, BC / / April 22, 2025 / Boron One Holdings Inc. ("Boron One" or the "Company") (TSXV:BONE), is providing an update to its press release dated April 7, 2025 announcing the warrant exercise incentive program. The Program is intended to encourage the exercise of up to 9,691,000 unlisted common share purchase warrants of the Company (the "Eligible Warrants") which were issued as part of the Company's private placements which closed on June 7, 2024, September 10, 2024 and September 25, 2024, respectively. Each Eligible Warrant is exercisable for one common share of the Company (each a "Common Share") at a price of $0.07 per Common Share. The Company intends to amend the exercise price to $0.05 (the "Warrant Repricing") for the term of the Warrant Incentive Program, following receipt of TSX Venture Exchange (the "Exchange") acceptance. All other terms of the Eligible Warrants will remain the same, including the expiry dates of December 7, 2026 for the June 7, 2024 Warrants, March 10, 2027 for the September 10, 2024 Warrants and March 25, 2027 for the September 25, 2024 Warrants. Upon the expiration of the Warrant Incentive Program, the exercise price of any unexercised Eligible Warrants will revert to the original exercise price of $0.07 per Common Share. To the extent that holders of Eligible Warrants ("Warrant Holders") take advantage of the opportunity to exercise their Eligible Warrants early, this will fund working capital purposes. Eligible Warrants that remain unexercised following the completion of the Early Exercise Period (defined below) will continue to be exercisable for Common Shares on the original terms as they existed prior to the Program. The Early Exercise Period will commence on April 23, 2025 and terminate on May 7, 2025. The Program and Warrant Repricing are subject to approval from the Exchange and the receipt of all final regulatory approvals, including final approval of the Exchange. Insiders presently hold 900,000 Eligible Warrants. The number of Eligible Warrants to be exercised by insiders of the Company is limited to no more than 10% of the total Eligible Warrants, being 969,100 Eligible Warrants, and the Company will issue no more than 969,100 Incentive Warrants to insiders under the Program. On behalf of the Board of Directors,Tim Daniels, President About Boron One Holdings One Holdings Inc. is an international mineral exploration and development company with boron assets in Serbia. Headquartered in Victoria, B.C., Canada, Boron One's shares are traded on the Exchange under the symbol "BONE". For detailed information please see Boron One's website at or the Company's filed documents at For further information, please contact: Boron One Holdings Inc. Blake Fallis, General Manager Phone: 1-250- 384-1999 or 1-888-289-3746 info@ Boron's Public Quotations:CanadaTSX Venture:BONEBerlin:EKVUS: SEC 12G3-2(B) #82-4432ERVFFOTC PINK:ERVFF Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE: Boron One Holdings Inc. View the original press release on ACCESS Newswire
